Stocktoria

SeaStar Medical Holding Corp ICU

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
3/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$1.2M$135,000$0
Gross profit$1.2M$135,000$0
Operating income-$12.2M-$17.8M-$14.2M-$11.6M-$4.4M
Net income-$12.2M-$24.8M-$26.2M-$12.2M-$4.6M
Operating cash flow-$13.6M-$16.0M-$10.3M-$7.8M-$5.1M
Total assets$14.2M$4.7M$3.5M$3.0M$603,000
Total liabilities$3.7M$6.8M$17.4M$23.8M$3.4M
Shareholders' equity$10.4M-$2.2M-$13.9M-$20.8M-$2.8M
Ratios
Gross margin95.7%100.0%
Operating margin-986.6%-13216.3%
Net margin-984.6%-18392.6%
Return on assets-85.8%-533.1%-746.7%-401.3%-762.2%
Return on equity-116.6%1137.4%189.1%58.7%163.2%
Debt / equity-0.30×-0.37×
Current ratio3.630.550.180.090.19
Revenue growth814.1%

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: n/a

Not applicable (financials/insurer or missing inputs).

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001831868 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.